Posters
Combination therapy of TERN-501, a selective agonist of thyroid hormone receptor (THR) beta with TERN-101, a farnesoid X receptor (FXR) agonist improves nonalcoholic steatohepatitis (NASH) in a GAN diet induced and biopsyconfirmed mouse model
June 21, 2023
European Association for the Study of the Liver (EASL) Liver Congress (2023)
A deep exploration of bridging fibrosis evolution and individual septa parameters in NASH using quantitative second harmonic generation imaging reveals fibrosis changes in natural history and treatment-induced not seen with conventional histology
June 21, 2023
European Association for the Study of the Liver (EASL) Liver Congress (2023)
Digital pathology using stain-free imaging indices allows direct prediction of all-cause mortality, hepatic decompensation and hepatocellular carcinoma development in patients with non-alcoholic fatty liver disease
June 21, 2023
European Association for the Study of the Liver (EASL) Liver Congress (2023)
Second Harmonic Generation (SHG)/Two-Photon Excitation Fluorescence (TPEF) Microscopy Imaging and Quantitative Assessment of Septa Fibrosis in Choline Deficient High Fat Diet (CDHFD) Rat Model of Nonalcoholic Steatohepatitis (NASH)
November 12, 2021
American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® Digital Experience (TLMdX) (2021)
BMS-986263 (Novel Targeted Lipid Nanoparticle Delivering HSP47 siRNA) Safety and Target Engagement in Patients with Advanced Hepatic Fibrosis: Week 36 Results from a Phase 2 Randomized, Double-blind, Placebo-controlled Trial
August 27, 2020
European Association for the Study of the Liver (EASL) Annual Congress 2020